Plasma Soluble Podoplanin as a Biomarker of Hypercoagulability and Cellular Immunity Status in Patients With Non-small Cell Lung Cancer
Podoplanin (PDPN) is known to play a role in thrombosis, metastasis of tumor cells, the epithelial–mesenchymal transition (EMT), and immune response. The present study aim to evaluate the clinical significance of soluble PDPN (sPDPN) in hypercoagulability and cellular immune status in patients with...
Main Authors: | Qian Zhang MM, Kun Peng MM, Lin Wang MM, Ru-Yu Zhang MM, Li-Hong Xin MM, Jing-Ying Huang MM, Yan-Min Zhang MD, Jie Zhao MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-06-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/10760296231183432 |
Similar Items
-
Elevated Soluble Podoplanin Associates with Hypercoagulability in Patients with Nephrotic Syndrome
by: Ying Ji MD, et al.
Published: (2022-07-01) -
microRNA-195 Promotes Small Cell Lung Cancer Cell Apoptosis via Inhibiting Rap2C Protein-Dependent MAPK Signal Transduction
by: Jichun Tong MM, et al.
Published: (2020-12-01) -
Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis
by: Hui-Zhu Qiu MM, et al.
Published: (2020-12-01) -
RORα and REV-ERBα are Associated With Clinicopathological Parameters and are Independent Biomarkers of Prognosis in Gastric Cancer
by: Xiaoshan Wang MM, et al.
Published: (2021-12-01) -
Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules
by: Yanzhen Lai MM, et al.
Published: (2022-05-01)